The Valeant saga: Why the world needs short sellers
Drug Short - Watch Free Online
Leerverkäufer : Andrew Left - der Mann, vor dem die Wall Street zittert | tagesschau.de
Andrew Left, owner and founder of Citron Research, stands for a... Nachrichtenfoto - Getty Images
Hacked Printers. Fake Emails. Questionable Friends. Fahmi Quadir Was Up 24% Last Year, But It Came at a Price. | Institutional Investor
Citron Short Valeant Again
The Valeant Meltdown and Wall Street's Major Drug Problem | Vanity Fair
Valeant short seller on the money — and facing trial in HK | The Australian
Valeant 'short' smells smoke — even when there's no fire
Drug Short - Watch Free Online
Fahmi Quadir: Die Shortsellerin, die gegen Valeant und Wirecard wettete | LGT
Short-Seller Chanos Turns Attention to Valeant - The New York Times
Watch Safkhet Capital's Quadir Is Still Short Valeant - Bloomberg
Valeant: Preispoker mit Medikamenten
The Anti-Ackman: Valeant Short Sellers Have Made $2.8 Billion - Bloomberg
Valeant Pharmaceuticals Rebuts Short Seller Claims Of Enron-Like Sham Transactions
Valeant's stock has plunged, so where are all the shorts? - The Globe and Mail
J. Michael Pearson - Wikipedia
Wirecard-Shortsellerin Fahmi Quadir: „Tesla ist aus vielen Gründen attraktiv für Shortseller“
Valeant shares jump 6 percent after analyst says 'short thesis has been debunked'
Jim Chanos: I'm still short Valeant and not about to quit
Valeant Short Seller Dials Back Warning of Bombshell Report on Monday - WSJ
Short Seller Famous for Bet Against Valeant Targets Tesla
Opinion: Time to short Valeant bonds, go long its stock - MarketWatch
Famed short-seller Chanos can't cash in on Valeant
